Gene · 4298
Papers1,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of biomarkers of Shenggu Zaizao Wan in the treatment of steroid-induced osteonecrosis of the femoral head by integrating network pharmacology and bulk transcriptomic. | Front Med (Lausanne) | 2026 | 41716792 | PubTator, text mining | PubMed |
| A Unique Case of Concomitant T-Prolymphocytic Leukemia and B-Cell Acute Lymphoblastic Leukemia. | EJHaem | 2026 | 41716292 | PubTator, text mining | PubMed |
| High-throughput ligand diversification to discover chemical inducers of proximity. | Nat Chem Biol | 2026 | 41699285 | PubTator, text mining | PubMed |
| From Serendipity to Strategy: Rationalizing Molecular Glue Discovery and Proximity-Induced Pharmacology through Chemical Biology. | J Am Chem Soc | 2026 | 41622634 | PubTator, text mining | PubMed |
| A Unified Model: Chromatin-Bound Multicomponent Condensates. | Cancer Res | 2026 | 41481253 | PubTator, text mining | PubMed |
| A chemical-genetic interaction between PAF1 and ENL/AF9 YEATS inhibition. | RSC Chem Biol | 2026 | 41142648 | PubTator, text mining | PubMed |
| Targeting the Menin-KMT2A interaction in leukemia: Lessons learned and future directions. | Int J Cancer | 2026 | 39887730 | PubTator, text mining | PubMed |
| Effect of pretransplant spleen volume on the prognosis of acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2025 | 41783603 | PubTator, text mining | PubMed |
| From ketogenic metabolism to targeted therapeutics: current advances in β-hydroxybutyrylation. | Front Immunol | 2025 | 41624834 | PubTator, text mining | PubMed |
| Genetic mutations in lymphocytic variant of hypereosinophilic syndrome: study of five siblings. | Front Med (Lausanne) | 2025 | 41488087 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| A chemical-genetic interaction between PAF1 and ENL/AF9 YEATS inhibition. | bioRxiv | 2025 | 40964345 | PubTator, text mining | PubMed |
| Synthesis, Structure-Activity Relationships, and Antitumor Activities of Quinoxiline-Containing Inhibitors of the Protein-Protein Interactions between Transcription Coactivator AF9/ENL and DOT1L/AF4. | J Med Chem | 2025 | 40957087 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain is a dual reader of histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking epigenetic and RNA signaling to regulate hematopoiesis. | bioRxiv | 2025 | 40950097 | PubTator, text mining | PubMed |
| High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity. | bioRxiv | 2025 | 40950085 | PubTator, text mining | PubMed |
| Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities. | Mol Cancer | 2025 | 40849651 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia - a polish paediatric population treated according to ALL-IC BFM 2009 protocol. | Sci Rep | 2025 | 40731127 | PubTator, text mining | PubMed |
| Development of Chemical Tools for the Human YEATS Domain. | ACS Chem Biol | 2025 | 40643381 | PubTator, text mining | PubMed |
| Functional Roles and Mechanistic Insights of YEATS Domain Proteins in Digestive System Tumors. | Dig Dis Sci | 2025 | 40571889 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4298/papers?page=2